Cargando…
Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury
Recent studies on liver disease burden worldwide estimated that cirrhosis is the 11th most common cause of death globally, and there is a great need for new therapies to limit the progression of liver injuries in the early stages. Cholestasis is caused by accumulation of hydrophobic bile acids (BA)...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392259/ https://www.ncbi.nlm.nih.gov/pubmed/34440614 http://dx.doi.org/10.3390/cells10081846 |